Joyce DE - Search Results

1

Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis.

Bernard GR, Macias WL, Joyce DE, Williams MD, Bailey J, Vincent JL. Bernard GR, et al. Among authors: joyce de. Crit Care. 2003 Apr;7(2):155-63. doi: 10.1186/cc2167. Epub 2003 Feb 28. Crit Care. 2003. PMID: 12720562 Free PMC article. Review.

2

Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation.

Dhainaut JF, Yan SB, Joyce DE, Pettilä V, Basson B, Brandt JT, Sundin DP, Levi M. Dhainaut JF, et al. Among authors: joyce de. J Thromb Haemost. 2004 Nov;2(11):1924-33. doi: 10.1111/j.1538-7836.2004.00955.x. J Thromb Haemost. 2004. PMID: 15550023 Free article.

3

Recombinant human activated protein C: a system modulator of vascular function for treatment of severe sepsis.

Grinnell BW, Joyce D. Grinnell BW, et al. Crit Care Med. 2001 Jul;29(7 Suppl):S53-60; discussion S60-1. doi: 10.1097/00003246-200107001-00020. Crit Care Med. 2001. PMID: 11445735 Review.

4

Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-kappaB.

Joyce DE, Grinnell BW. Joyce DE, et al. Crit Care Med. 2002 May;30(5 Suppl):S288-93. doi: 10.1097/00003246-200205001-00019. Crit Care Med. 2002. PMID: 12004250 Review.

5

The cancer related thrombotic tendency in sepsis.

Joyce DE. Joyce DE. Curr Drug Targets. 2007 Apr;8(4):543-9. doi: 10.2174/138945007780362773. Curr Drug Targets. 2007. PMID: 17430125 Review.

6

Leukocyte and endothelial cell interactions in sepsis: relevance of the protein C pathway.

Joyce DE, Nelson DR, Grinnell BW. Joyce DE, et al. Crit Care Med. 2004 May;32(5 Suppl):S280-6. doi: 10.1097/01.ccm.0000128037.72072.22. Crit Care Med. 2004. PMID: 15118531 Review.

7

Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia.

Kerlin BA, Yan SB, Isermann BH, Brandt JT, Sood R, Basson BR, Joyce DE, Weiler H, Dhainaut JF. Kerlin BA, et al. Among authors: joyce de. Blood. 2003 Nov 1;102(9):3085-92. doi: 10.1182/blood-2003-06-1789. Epub 2003 Jul 17. Blood. 2003. PMID: 12869495 Free article.

8

Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis.

Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW. Joyce DE, et al. J Biol Chem. 2001 Apr 6;276(14):11199-203. doi: 10.1074/jbc.C100017200. Epub 2001 Feb 5. J Biol Chem. 2001. PMID: 11278252 Free article.

9

17beta-estradiol, but not raloxifene, decreases thrombomodulin in the antithrombotic protein C pathway.

Richardson MA, Berg DT, Calnek DS, Ciaccia AV, Joyce DE, Grinnell BW. Richardson MA, et al. Among authors: joyce de. Endocrinology. 2000 Oct;141(10):3908-11. doi: 10.1210/endo.141.10.7798. Endocrinology. 2000. PMID: 11014248

10

Sepsis.

Joyce DE. Joyce DE. Curr Drug Targets. 2007 Apr;8(4):491. doi: 10.2174/138945007780362755. Curr Drug Targets. 2007. PMID: 17430118 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters